Geriatric depression and vascular diseases: what are the links?
暂无分享,去创建一个
Gérard Waeber | M. Preisig | G. Waeber | C. Büla | V. Camus | Martin Preisig | Christophe J Büla | Vincent Camus | Hélène Kraehenbühl | Hélène Kraehenbühl
[1] C. Nemeroff,et al. Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings. , 2001, The American journal of psychiatry.
[2] P. Boutin,et al. Islet-brain1/C-Jun N-terminal kinase interacting protein-1 (IB1/JIP-1) promoter variant is associated with Alzheimer's disease , 2003, Molecular Psychiatry.
[3] C. Jones,et al. Arterial endothelial function is impaired in treated depression , 2002, Heart.
[4] Casey Crump,et al. Cerebrovascular Disease and Evolution of Depressive Symptoms in the Cardiovascular Health Study , 2002, Stroke.
[5] G. Breithardt,et al. Affective disorders and survival after acute myocardial infarction. Results from the post-infarction late potential study. , 1991, European heart journal.
[6] C. Marra,et al. Frequency, phenomenology and anatomical–clinical correlates of major post-stroke depression , 1999, British Journal of Psychiatry.
[7] John T. O'Brien,et al. White Matter Changes in Depression and Alzheimer's Disease: A Review of Magnetic Resonance Imaging Studies , 1996 .
[8] H. Kraemer,et al. A longitudinal study of apolipoprotein-E genotype and depressive symptoms in community-dwelling older adults. , 2000, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[9] J. Ormel,et al. Depression in survivors of stroke: a community-based study of prevalence, risk factors and consequences , 1998, Social Psychiatry and Psychiatric Epidemiology.
[10] C. Nemeroff,et al. Exaggerated platelet reactivity in major depression. , 1996, The American journal of psychiatry.
[11] D. C. Olivier,et al. Affective disorders and mortality. A general population study. , 1987, Archives of general psychiatry.
[12] C. Di Menza,et al. VLDL receptor polymorphism, cognitive impairment, and dementia , 2001, Neurology.
[13] M Ashtari,et al. MRI signal hyperintensities in geriatric depression. , 1996, The American journal of psychiatry.
[14] C. Mazure,et al. Depression in late life: age of onset as marker of a subtype. , 1989, Journal of affective disorders.
[15] A Jordan,et al. Depression in Europe , 1999, British Journal of Psychiatry.
[16] R. Califf,et al. Depression and long-term mortality risk in patients with coronary artery disease. , 1996, The American journal of cardiology.
[17] D. Charney,et al. Receptor sensitivity and the mechanism of action of antidepressant treatment. Implications for the etiology and therapy of depression. , 1981, Archives of general psychiatry.
[18] T. Tanigawa,et al. Prospective study of depressive symptoms and risk of stroke among japanese. , 2001, Stroke.
[19] F. Fazekas,et al. Pathologic correlates of incidental MRI white matter signal hyperintensities , 1993, Neurology.
[20] Jong S. Kim. Cytokines and adhesion molecules in stroke and related diseases , 1996, Journal of the Neurological Sciences.
[21] R F Spetzler,et al. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. II. Postmortem pathological correlations. , 1986, Stroke.
[22] M. Fava,et al. Serum cholesterol and serotonergic function in major depressive disorder , 2003, Psychiatry Research.
[23] J. Grace,et al. Association of life events and psychosocial factors with early but not late onset depression in the elderly: implications for possible differences in aetiology , 2003, International journal of geriatric psychiatry.
[24] A. Döring,et al. Influence of depressive mood on the association of CRP and obesity in 3205 middle aged healthy men , 2003, Brain, Behavior, and Immunity.
[25] Michael Sharpe,et al. Depression after stroke and lesion location: a systematic review , 2000, The Lancet.
[26] B. Tress,et al. Severe deep white matter lesions and outcome in elderly patients with major depressive disorder: follow up study , 1998, BMJ.
[27] L. Lipsitz,et al. The microvascular frontal-subcortical syndrome of aging , 2002, Neurobiology of Aging.
[28] R. Jaenisch,et al. Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. , 2001, Molecular endocrinology.
[29] D. Bush,et al. Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. , 2000, Archives of internal medicine.
[30] Suzanne Corkin,et al. Visual dysfunction in Alzheimer's disease: Relation to normal aging , 1991, Annals of neurology.
[31] E. Sprague,et al. The association of elevated plasma cortisol and early atherosclerosis as demonstrated by coronary angiography. , 1977, Atherosclerosis.
[32] J T O'Brien,et al. Elevation in late-life depression of intercellular adhesion molecule-1 expression in the dorsolateral prefrontal cortex. , 2000, The American journal of psychiatry.
[33] P. Valonen,et al. Use of psychotropic drugs and risk of myocardial infarction: a case-control study in Finnish farmers. , 1996, International journal of epidemiology.
[34] R. Carney,et al. Severe depression is associated with markedly reduced heart rate variability in patients with stable coronary heart disease. , 2000, Journal of psychosomatic research.
[35] A. Beekman,et al. Depression in later life: three etiologically different subgroups. , 2001, Journal of affective disorders.
[36] G. Alexopoulos,et al. Clinically defined vascular depression. , 1997, The American journal of psychiatry.
[37] C. Schacky,et al. n−3 Fatty acids and the prevention of coronary atherosclerosis , 2000 .
[38] J. Lépine,et al. Relationship between attempted suicide, serum cholesterol level and novelty seeking in psychiatric in-patients , 2002, Psychiatry Research.
[39] H. Stassen,et al. Mortality of patients with mood disorders: follow-up over 34-38 years. , 2002, Journal of affective disorders.
[40] B. Pollock,et al. Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment. , 2000, Journal of clinical psychopharmacology.
[41] R. Carney,et al. Depression and Coronary Heart Disease in Women With Diabetes , 2003, Psychosomatic medicine.
[42] B. Leonard,et al. Depression, stress and immunological activation: the role of cytokines in depressive disorders. , 1998, Life sciences.
[43] P. Amouyel,et al. Interactions between Apolipoprotein E and Apolipoprotein(a) in Patients with Late-Onset Alzheimer Disease , 2000, Annals of Internal Medicine.
[44] Phyllis K. Stein,et al. Effects of Depression on QT Interval Variability After Myocardial Infarction , 2003, Psychosomatic medicine.
[45] B. Pollock,et al. Changes in cognitive functioning following treatment of late-life depression. , 2000, The American journal of psychiatry.
[46] K. Krishnan,et al. Subcortical hyperintensities on brain magnetic resonance imaging: A comparison between late age onset and early onset elderly depressed subjects , 1991, Neurobiology of Aging.
[47] R. Carney,et al. Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms. , 2002, Journal of psychosomatic research.
[48] D. Blazer,et al. APOE ɛ4 and Low Cholesterol as Risks for Depression in a Biracial Elderly Community Sample , 2002 .
[49] E. Chen,et al. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen , 1987, Nature.
[50] K. Freedland,et al. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. , 2001, Diabetes care.
[51] C. Altar. Neurotrophins and depression. , 1999, Trends in pharmacological sciences.
[52] R. Rosenman,et al. Coronary heart disease in the Western Collaborative Group Study , 1970 .
[53] C. Anderson,et al. Prevalence of Depression After Stroke: The Perth Community Stroke Study , 1995, British Journal of Psychiatry.
[54] E. Welker,et al. Spatial, temporal and subcellular localization of islet‐brain 1 (IB1), a homologue of JIP‐1, in mouse brain , 2000, The European journal of neuroscience.
[55] C. Nemeroff,et al. Are platelets the link between depression and ischemic heart disease? , 2000, American heart journal.
[56] James R. MacFall,et al. Localization of age-associated white matter hyperintensities in late-life depression , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[57] A. Burns,et al. Is subcortical disease associated with a poor response to antidepressants? Neurological, neuropsychological and neuroradiological findings in late-life depression , 1998, Psychological Medicine.
[58] D. Ford,et al. Depression and Risk for Onset of Type II Diabetes: A prospective population-based study , 1996, Diabetes Care.
[59] Irl B Hirsch,et al. The relationship of depressive symptoms to symptom reporting, self-care and glucose control in diabetes. , 2003, General hospital psychiatry.
[60] G. Zubenko,et al. Association of the APOE ε4 allele with clinical subtypes of late life depression , 1996, Biological Psychiatry.
[61] H. Krumholz,et al. Depression and Risk of Heart Failure Among the Elderly: A Prospective Community-Based Study , 2002, Psychosomatic medicine.
[62] C. DeCarli,et al. Midlife cardiovascular risk factors and brain morphology in identical older male twins , 1999, Neurology.
[63] C. Kilts,et al. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. , 1984, Science.
[64] D. Horrobin,et al. Phospholipid metabolism and depression: the possible roles of phospholipase A2 and coenzyme A‐independent transacylase , 2001, Human psychopharmacology.
[65] L. Kuller,et al. Are predictors of coronary heart disease and lower-extremity arterial disease in type 1 diabetes the same? A prospective study. , 2000, Atherosclerosis.
[66] Salvatore Giaquinto,et al. Depression after stroke: an investigation through catamnesis. , 1997, The Journal of clinical psychiatry.
[67] C. Lyketsos,et al. A double blind, randomized clinical trial assessing the efficacy and safety of augmenting standard antidepressant therapy with nimodipine in the treatment of ‘vascular depression’ , 2001, International journal of geriatric psychiatry.
[68] E H Cook,et al. Primary Structure of the Human Platelet Serotonin 5‐HT2A Receptor: Identity with Frontal Cortex Serotonin 5‐HT2A Receptor , 1994, Journal of neurochemistry.
[69] C. Dina,et al. The gene MAPK8IP1, encoding islet-brain-1, is a candidate for type 2 diabetes , 2000, Nature Genetics.
[70] F. Panza,et al. Lipoprotein(a), apolipoprotein E genotype, and risk of Alzheimer's disease , 2002, Journal of neurology, neurosurgery, and psychiatry.
[71] J. Salonen,et al. Hopelessness and Risk of Mortality and Incidence of Myocardial Infarction and Cancer , 1996, Psychosomatic medicine.
[72] K. Nakashima,et al. Lipoprotein(a) Phenotypes in Patients with Vascular Dementia , 2000, Dementia and Geriatric Cognitive Disorders.
[73] R. Brand,et al. Coronary heart disease in Western Collaborative Group Study. Final follow-up experience of 8 1/2 years. , 1975, JAMA.
[74] K. Krishnan,et al. Allelic differences in the serotonin transporter-linked polymorphic region in geriatric depression. , 2002, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[75] C. Coffey,et al. Quantitative cerebral anatomy of the aging human brain , 1992, Neurology.
[76] T. Kamarck,et al. Depressive symptomatology and coronary heart disease in Type I diabetes mellitus: a study of possible mechanisms. , 2002, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.
[77] L. Pike,et al. Cholesterol levels modulate EGF receptor-mediated signaling by altering receptor function and trafficking. , 2002, Biochemistry.
[78] K. Krishnan,et al. Cerebrovascular disease and depression symptoms in the cardiovascular health study. , 1999, Stroke.
[79] E. Vartiainen,et al. High serum cholesterol and risk of suicide. , 2000, The American journal of psychiatry.
[80] James A. Blumenthal,et al. Depression, Heart Rate Variability, and Acute Myocardial Infarction , 2001, Circulation.
[81] N. Schneiderman,et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. , 2003, JAMA.
[82] Emmanuel Mignot,et al. Future of genetics of mood disorders research , 2002, Biological Psychiatry.
[83] L. Liscum,et al. Quantitative analysis of hydrophobic amine inhibition of intracellular cholesterol transport. , 1996, Journal of lipid research.
[84] M Ashtari,et al. Neuropsychological functioning and MRI signal hyperintensities in geriatric depression. , 1999, The American journal of psychiatry.
[85] P. Rabins,et al. Phenomenological comparison of poststroke depression and functional depression. , 1986, The American journal of psychiatry.
[86] A. Leaf,et al. ω3 Fatty Acids and Cardiovascular Disease , 1998 .
[87] R. Robinson,et al. Are depressive symptoms nonspecific in patients with acute stroke? , 1991, The American journal of psychiatry.
[88] John J. Campbell,et al. Neuropsychiatric Significance of Subcortical Hyperintensity , 2001 .
[89] E. Caine,et al. Depression, Medical Illness, and Interleukin-1β in Older Cardiac Patients , 2001, International journal of psychiatry in medicine.
[90] I. Skoog,et al. The incidence of first-onset depression in a population followed from the age of 70 to 85 , 2001, Psychological Medicine.
[91] A. Beekman,et al. Review of community prevalence of depression in later life , 1999, British Journal of Psychiatry.
[92] E. Eaker,et al. Depressed Affect, Hopelessness, and the Risk of Ischemic Heart Disease in a Cohort of U.S. Adults , 1993, Epidemiology.
[93] D. Swaab,et al. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. , 1994, Neuroendocrinology.
[94] G L Wolf,et al. Brain imaging abnormalities in mental disorders of late life. , 1990, Archives of neurology.
[95] F. Boller,et al. Apolipoprotein E ϵ4 Allele and Clinically Defined Vascular Depression , 2002 .
[96] D. Ford,et al. Depression is a risk factor for coronary artery disease in men: the precursors study. , 1998, Archives of internal medicine.
[97] J. Lönnqvist,et al. Association of low serum total cholesterol with major depression and suicide , 1999, British Journal of Psychiatry.
[98] M. Fava,et al. Elevated cholesterol levels associated with nonresponse to fluoxetine treatment in major depressive disorder. , 2002, Psychosomatics.
[99] D. Horrobin. Abnormal membrane concentrations of 20 and 22-carbon essential fatty acids: a common link between risk factors and coronary and peripheral vascular disease? , 1995, Prostaglandins, leukotrienes, and essential fatty acids.
[100] B. Pollock,et al. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. , 1998, JAMA.
[101] F. Post. The Management and Nature of Depressive Illnesses in Late Life: A Follow-Through Study , 1972, British Journal of Psychiatry.
[102] P. Videbech. MRI findings in patients with affective disorder: a meta‐analysis , 1997, Acta psychiatrica Scandinavica.
[103] C. Coffey,et al. Leukoencephalopathy in elderly depressed patients referred for ECT , 1988, Biological Psychiatry.
[104] D. Horrobin,et al. Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. , 1998, Journal of affective disorders.
[105] P. Vokonas,et al. Prospective study of a self-report type A scale and risk of coronary heart disease: test of the MMPI-2 type A scale. , 1998, Circulation.
[106] Yong-Ku Kim,et al. Low serum cholesterol is correlated to suicidality in a Korean sample , 2002, Acta psychiatrica Scandinavica.
[107] H. Shimizu,et al. Depressive symptoms and occurrence of type 2 diabetes among Japanese men. , 1999, Diabetes care.
[108] N. Frasure-smith,et al. Depression and 18-month prognosis after myocardial infarction. , 1995, Circulation.
[109] R. Baldwin,et al. Subcortical Hyperintensities in Late-Life Depression: Acute Response to Treatment and Neuropsychological Impairment , 1997, International Psychogeriatrics.
[110] G. Alexopoulos,et al. Subtypes of cognitive impairment in depressed older adults. , 2000, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[111] A. Leaf,et al. Omega-3 fatty acids and cardiovascular disease. , 2001, World review of nutrition and dietetics.
[112] M. Dimatteo,et al. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. , 2000, Archives of internal medicine.
[113] C. Reynolds,et al. Relationship of deep white matter hyperintensities and apolipoprotein E genotype to depressive symptoms in older adults without clinical depression. , 2001, The American journal of psychiatry.
[114] P. Burger,et al. Subcortical arteriosclerotic encephalopathy: brain stem findings with MR imaging. , 1987, Radiology.
[115] K. Asplund,et al. Major Depression in Stroke Patients: A 3‐Year Longitudinal Study , 1993, Stroke.
[116] C. A. de Mendonça Lima,et al. Are personality disorders more frequent in early onset geriatric depression? , 1997, Journal of affective disorders.
[117] C. Mehringer,et al. Apolipoprotein-E and white-matter hyperintensities in late-life depression. , 2000, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[118] B L Miller,et al. Cognition and white matter hyperintensities in older depressed patients. , 1996, The American journal of psychiatry.
[119] J. Sweeney,et al. Involutional melancholia revisited. , 1984, The American journal of psychiatry.
[120] I. Hickie,et al. Early and late onset depression in old age: different aetiologies, same phenomenology. , 2001, Journal of affective disorders.
[121] E. Kraepelin. Psychiatrie : ein Lehrbuch für Studi[e]rende und Aerzte , 1976 .
[122] K. Krishnan,et al. Neuroanatomical substrates of depression in the elderly , 2005, European Archives of Psychiatry and Clinical Neuroscience.
[123] R. Ramasubbu. Insulin resistance: a metabolic link between depressive disorder and atherosclerotic vascular diseases. , 2002, Medical hypotheses.
[124] A. Hofman,et al. Cerebral white matter lesions and depressive symptoms in elderly adults. , 2000, Archives of general psychiatry.
[125] B. Pollock,et al. Elevated platelet factor 4 and β-thromboglobulin plasma levels in depressed patients with ischemic heart disease , 1997, Biological Psychiatry.
[126] J. Bigger,et al. Cardiovascular effects of fluoxetine in depressed patients with heart disease. , 1998, The American journal of psychiatry.
[127] R. Crum,et al. Depression, psychotropic medication, and risk of myocardial infarction. Prospective data from the Baltimore ECA follow-up. , 1996, Circulation.
[128] J. Lion. Personality disorders : diagnosis and management , 1974 .
[129] D. Bush,et al. The Significance of Depression in Older Patients After Myocardial Infarction , 2002, Journal of the American Geriatrics Society.
[130] Angela L. Lee,et al. Stress and depression: possible links to neuron death in the hippocampus. , 2002, Bipolar disorders.
[131] E. Nestler,et al. A molecular and cellular theory of depression. , 1997, Archives of general psychiatry.
[132] B. MacVicar,et al. Potassium-dependent calcium influx in acutely isolated hippocampal astrocytes , 1994, Neuroscience.
[133] G. Alexopoulos,et al. 'Vascular depression' hypothesis. , 1997, Archives of general psychiatry.
[134] I. Ferrier,et al. Structural and functional abnormalities in elderly patients clinically recovered from early- and late-onset depression , 1998, Biological Psychiatry.
[135] R. Carney,et al. Major depression and medication adherence in elderly patients with coronary artery disease. , 1995, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.
[136] G. Alexopoulos. "The depression-executive dysfunction syndrome of late life": a specific target for D3 agonists? , 2001, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[137] H. Meltzer,et al. Fatty acid composition in major depression: decreased ω3 fractions in cholesteryl esters and increased C20:4ω6C20:5ω3 ratio in cholesteryl esters and phospholipids , 1996 .
[138] T. Iidaka,et al. Signal hyperintensities on brain magnetic resonance imaging in elderly depressed patients. , 1996, European neurology.
[139] E. Boerwinkle,et al. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. , 1992, The Journal of clinical investigation.
[140] G. Alexopoulos,et al. Late-onset depression. , 1988, The Psychiatric clinics of North America.
[141] K. Pfeiffer,et al. Lipoprotein(a) as a strong indicator for cerebrovascular disease. , 1986, Stroke.
[142] Frank Bellivier,et al. Psychiatric genetics: search for phenotypes , 1998, Trends in Neurosciences.
[143] S. Holroyd,et al. Differences in geriatric psychiatry outpatients with early‐ vs late‐onset depression , 1997, International journal of geriatric psychiatry.
[144] G. Alexopoulos,et al. The course of geriatric depression with "reversible dementia": a controlled study. , 1993, The American journal of psychiatry.
[145] A. Nouwen,et al. A review of the relationship between depression and diabetes in adults: is there a link? , 2000, Diabetes care.
[146] C. Tangen,et al. Depressive Symptoms and Risks of Coronary Heart Disease and Mortality in Elderly Americans , 2000 .
[147] Robert Barber,et al. Ischemic basis for deep white matter hyperintensities in major depression: a neuropathological study. , 2002, Archives of general psychiatry.
[148] A. Thomas,et al. Is apolipoprotein e4 associated with cognitive decline in depression? , 2001, International journal of geriatric psychiatry.
[149] P. Zwanzger,et al. Combined action of the ACE D- and the G-protein β3 T-allele in major depression: a possible link to cardiovascular disease? , 2002, Molecular Psychiatry.
[150] G. Andersen,et al. Incidence of post‐stroke depression during the first year in a large unselected stroke population determined using a valid standardized rating scale , 1994, Acta psychiatrica Scandinavica.
[151] C. Nemeroff,et al. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. , 1998, Archives of general psychiatry.
[152] J. Blumenthal,et al. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. , 1999, Circulation.
[153] A. J. Kumar,et al. Cortical magnetic resonance imaging changes in elderly inpatients with major depression. , 1991, The American journal of psychiatry.
[154] I. Hickie,et al. Late-onset depression: genetic, vascular and clinical contributions , 2001, Psychological Medicine.
[155] M. Mussolino,et al. Symptoms of Depression as a Prospective Risk Factor for Stroke , 2000, Psychosomatic medicine.
[156] Henry Brodaty,et al. Subcortical hyperintensities on magnetic resonance imaging in patients with severe depression—A longitudinal evaluation , 1997, Biological Psychiatry.
[157] H. S. Davis,et al. A Controlled Study , 1966 .
[158] Alan J. Thomas,et al. Cell adhesion molecule expression in the dorsolateral prefrontal cortex and anterior cingulate cortex in major depression in the elderly , 2002, British Journal of Psychiatry.
[159] P. Vanhoutte. Platelet‐Derived Serotonin, the Endothelium, and Cardiovascular Disease , 1991, Journal of cardiovascular pharmacology.
[160] B. Fagerberg,et al. Negative feelings (discontent) predict progress of intima-media thickness of the common carotid artery in treated hypertensive men at high cardiovascular risk. , 1996, American journal of hypertension.
[161] J. Toole,et al. The prevalence and severity of white matter lesions, their relationship with age, ethnicity, gender, and cardiovascular disease risk factors: the ARIC Study. , 1997, Neuroepidemiology.
[162] B L Miller,et al. Evidence for genetic variance in white matter hyperintensity volume in normal elderly male twins. , 1998, Stroke.
[163] A. Schousboe,et al. Localization and pharmacological characterization of voltage dependent calcium channels in cultured neocortical neurons , 2001, International Journal of Developmental Neuroscience.
[164] K. Krishnan,et al. Apolipoprotein E-ε4 frequency in geriatric depression , 1996, Biological Psychiatry.
[165] I. Ferrier,et al. A neuropathological study of vascular factors in late-life depression , 2001, Journal of neurology, neurosurgery, and psychiatry.
[166] Svante B. Ross,et al. Binding of some antidepressants to the 5-hydroxytryptamine transporter in brain and platelets , 2005, Psychopharmacology.
[167] R. Carney,et al. Depression in patients with coronary heart disease. A 12-month follow-up. , 1996, General hospital psychiatry.
[168] B. Penninx,et al. Depression and cardiac mortality: results from a community-based longitudinal study. , 2001, Archives of general psychiatry.
[169] K. Krishnan,et al. MRI-defined vascular depression. , 1997, The American journal of psychiatry.
[170] M. Rubenfire,et al. Abnormal brachial artery flow-mediated vasodilation in young adults with major depression. , 2001, The American journal of cardiology.
[171] G. Alexopoulos,et al. Geriatric depression: Age of onset and dementia , 1993, Biological Psychiatry.
[172] D. Horrobin,et al. Depression and bipolar disorder: relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis. Possible candidate genes. , 1999, Prostaglandins, leukotrienes, and essential fatty acids.
[173] R. Kikinis,et al. White matter changes with normal aging , 1998, Neurology.